Zoetis Inc. [NYSE: ZTS] price plunged by -0.54 percent to reach at -$0.87. The company report on November 16, 2020 that Zoetis is First Animal Health Company to Issue Environmental, Social and Governance (ESG) Review Based on Leading Sustainability Frameworks.
Comprehensive historical data illustrates improvements in environmental metrics, highly engaged workforce, community and veterinary support, and ambitions for a more diverse and inclusive workforce.
Addition of new leaders and responsibilities dedicated to ESG areas.
A sum of 1980782 shares traded at recent session while its average daily volume was at 1.64M shares. Zoetis Inc. shares reached a high of $162.68 and dropped to a low of $159.245 until finishing in the latest session at $160.19.
The one-year ZTS stock forecast points to a potential upside of 13.41. The average equity rating for ZTS stock is currently 2.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Zoetis Inc. [ZTS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZTS shares is $185.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZTS stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Atlantic Equities have made an estimate for Zoetis Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on September 21, 2020. The new note on the price target was released on August 14, 2020, representing the official price target for Zoetis Inc. stock.
The Average True Range (ATR) for Zoetis Inc. is set at 4.29, with the Price to Sales ratio for ZTS stock in the period of the last 12 months amounting to 11.65. The Price to Book ratio for the last quarter was 21.13. Price to Free Cash Flow for ZTS in the course of the last twelve months was 65.73 with Quick ratio for the last quarter at 2.10.
ZTS Stock Performance Analysis:
Zoetis Inc. [ZTS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.02. With this latest performance, ZTS shares dropped by -1.40% in over the last four-week period, additionally plugging by 14.92% over the last 6 months – not to mention a rise of 31.42% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZTS stock in for the last two-week period is set at 42.88, with the RSI for the last a single of trading hit 37.31, and the three-weeks RSI is set at 46.00 for Zoetis Inc. [ZTS]. The present Moving Average for the last 50 days of trading for this stock 163.22, while it was recorded at 163.62 for the last single week of trading, and 143.90 for the last 200 days.
Insight into Zoetis Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Zoetis Inc. [ZTS] shares currently have an operating margin of +32.24 and a Gross Margin at +65.70. Zoetis Inc.’s Net Margin is presently recorded at +23.96.
Return on Total Capital for ZTS is now 22.43, given the latest momentum, and Return on Invested Capital for the company is 17.19. Return on Equity for this stock inclined to 61.31, with Return on Assets sitting at 13.44. When it comes to the capital structure of this company, Zoetis Inc. [ZTS] has a Total Debt to Total Equity ratio set at 245.42. Additionally, ZTS Total Debt to Total Capital is recorded at 71.05, with Total Debt to Total Assets ending up at 57.57. Long-Term Debt to Equity for the company is recorded at 225.66, with the Long-Term Debt to Total Capital now at 65.33.
Reflecting on the efficiency of the workforce at the company, Zoetis Inc. [ZTS] managed to generate an average of $141,509 per employee. Receivables Turnover for the company is 5.90 with a Total Asset Turnover recorded at a value of 0.56.Zoetis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.10 and a Current Ratio set at 2.80.
ZTS Stock EPS
With the latest financial reports released by the company, Zoetis Inc. posted 0.92/share EPS, while the average EPS was predicted by analysts to be reported at 0.88/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 4.50%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ZTS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Zoetis Inc. go to 9.91%.
Zoetis Inc. [ZTS] Insider Position Details
There are presently around $69,962 million, or 94.70% of ZTS stock, in the hands of institutional investors. The top three institutional holders of ZTS stocks are: BLACKROCK INC. with ownership of 39,429,316, which is approximately -1.819% of the company’s market cap and around 0.08% of the total institutional ownership; VANGUARD GROUP INC, holding 37,450,478 shares of the stock with an approximate value of $6.0 billion in ZTS stocks shares; and STATE STREET CORP, currently with $3.22 billion in ZTS stock with ownership of nearly -1.816% of the company’s market capitalization.
Positions in Zoetis Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 636 institutional holders increased their position in Zoetis Inc. [NYSE:ZTS] by around 16,094,442 shares. Additionally, 544 investors decreased positions by around 16,179,087 shares, while 181 investors held positions by with 404,468,908 shares. The mentioned changes placed institutional holdings at 436,742,437 shares, according to the latest SEC report filing. ZTS stock had 127 new institutional investments in for a total of 1,102,618 shares, while 57 institutional investors sold positions of 1,105,487 shares during the same period.